Archer Investment Corporation’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-488
Closed -$19.8K – 1206
2025
Q2
$19.8K Buy
488
+2
+0.4% +$82 ﹤0.01% 602
2025
Q1
$23.6K Hold
486
– – 0.01% 562
2024
Q4
$21.4K Buy
486
+2
+0.4% +$100 0.01% 570
2024
Q3
$27K Buy
484
+2
+0.4% +$109 0.01% 529
2024
Q2
$24.5K Hold
482
– – 0.01% 519
2024
Q1
$25.6K Hold
482
– – 0.01% 501
2023
Q4
$22K Sell
482
-124
-20% -$5.19K 0.01% 514
2023
Q3
$25K Hold
606
– – 0.01% 476
2023
Q2
$27K Buy
+606
New +$26.7K 0.01% 465

Other funds holding RXL

Archer Investment Corporation's RXL Position: Q3 2025 in Review

Archer Investment Corporation sold out of ProShares Ultra Health Care (RXL) in Q3 2025, closing a stake of 488 shares — an estimated $19.8K sold.

Archer Investment Corporation first reported a position in RXL in Q2 2023 and held it in 9 quarters. The position peaked at $27K in Q3 2024. 18 funds tracked by Wall St. Rank hold RXL as of Q3 2025.

  • Archer Investment Corporation reported no remaining ProShares Ultra Health Care position as of Q3 2025 after selling out during the quarter.
  • Archer Investment Corporation sold 488 ProShares Ultra Health Care shares in Q3 2025, an estimated $19.8K.
  • Archer Investment Corporation first reported a position in ProShares Ultra Health Care in Q2 2023 and held it in 9 quarters.
  • Archer Investment Corporation's ProShares Ultra Health Care position peaked at $27K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2025.

Based on Archer Investment Corporation's 13F filing for Q3 2025, filed 3 Nov 2025.